Melanoma Prognosis and Staging

February 10, 2020

Abstract

A standardized, uniformly accepted cancer staging system is an essential and fundamental requirement for meaningful comparisons to be made across patient populations. In the case of melanoma, the identification of increasingly powerful prognostic factors has led to sequential modifications of the cutaneous melanoma staging system. The American Joint Committee on Cancer (AJCC) Melanoma Expert Panel significantly revised the melanoma staging system in 2017, and the current eighth edition AJCC melanoma staging system is the most widely accepted approach to melanoma staging and classification. This chapter reviews the prognostic factors relevant to current melanoma practice with an emphasis on factors that have significance in contemporary statistical analyses, using the eighth edition AJCC melanoma staging system and an international database analysis as a framework.

Source:

Keung E.Z. et al. (2020) Melanoma Prognosis and Staging. In: Balch C. et al. (eds) Cutaneous Melanoma. Springer, Cham

https://link.springer.com/referenceworkentry/10.1007%2F978-3-030-05070-2_4